• Home
  • Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer.

Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer.

Author List
Koshkin VS, Mir MC, Barata P, Gul A, Gupta R, Stephenson AJ, Kaouk J, Berglund R, Magi-Galluzzi C, Klein EA, Dreicer R, Garcia JA
Publication
Investigational new drugs
Publication ID (Profile URL)
https://researcherprofiles.org/profile/49731932
Publication Year
2019
PubMed ID
31037562
Publication Title
Koshkin VS, Mir MC, Barata P, Gul A, Gupta R, Stephenson AJ, Kaouk J, Berglund R, Magi-Galluzzi C, Klein EA, Dreicer R, Garcia JA. Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer. Invest New Drugs. 2019 06; 37(3):559-566.